Cargando…

Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Citterio, Chiara, Lazzaro, Antonio, Bosi, Costanza, De Ponzio, Maurice, Cavanna, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190583/ https://www.ncbi.nlm.nih.gov/pubmed/34136224 http://dx.doi.org/10.1002/ccr3.4013

Ejemplares similares

Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey: Consideration of recent findings on COVID-19 vaccine adherence in cancer patients
por: Cavanna, Luigi, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
por: Civriz Bozdağ, Sinem, et al.
Publicado: (2022)

COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
por: Cavanna, Luigi, et al.
Publicado: (2021)

Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012)

The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021)

Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer
por: Cavanna, Luigi, et al.
Publicado: (2020)

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022)

Herpes Zoster Following COVID-19 Vaccination in Long-Term Breast Cancer Survivors
por: Toscani, Ilaria, et al.
Publicado: (2021)

COVID-19 in Hematological Malignancies: Case Series and Literature Review
por: Ocheni, Sunday, et al.
Publicado: (2023)

Risk factors and outcome of COVID-19 in patients with hematological malignancies
por: Piñana, José Luis, et al.
Publicado: (2020)

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19
por: Cook, Michael Roderick, et al.
Publicado: (2020)

Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
por: Cook, Michael R., et al.
Publicado: (2022)

Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies
por: Chien, Kelly S., et al.
Publicado: (2022)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes
por: Min, Hong Ki, et al.
Publicado: (2015)

COVID-19 in Hematologic Malignancies: Big Challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
por: Levi, Marcel
Publicado: (2021)

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis
por: Cavanna, Luigi, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy
por: Ambroggi, Massimo, et al.
Publicado: (2022)

Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing
por: Hallmeyer, Sigrun, et al.
Publicado: (2023)

Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature
por: Cavanna, Luigi, et al.
Publicado: (2023)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
por: Assi, Tarek, et al.
Publicado: (2020)

COVID-19 and Hematologic Malignancies: Single Institution Analysis
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
por: Borah, Pronamee, et al.
Publicado: (2021)

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021)

Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience
por: Ababneh, Hazim, et al.
Publicado: (2021)

Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study
por: Acar, Ibrahim Halil, et al.
Publicado: (2022)

Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy
por: Seki, Masafumi, et al.
Publicado: (2022)

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
por: Zappasodi, Patrizia, et al.
Publicado: (2022)

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
por: Pagano, Livio, et al.
Publicado: (2021)

COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
por: Lattenist, R., et al.
Publicado: (2020)

COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients()
por: Colombi, Davide, et al.
Publicado: (2021)

Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mdqb7dsaav0hrifmhhdna93kch